首页 | 本学科首页   官方微博 | 高级检索  
     


A bactericidal product obtained from a mutant of Escherichia coli
Authors:N Zwaig  E Diéguez
Affiliation:1. Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, CA 94608-2916, USA;2. Target Discovery Institute and Structural Genomics Consortium, University of Oxford, NDM Research Building, Roosevelt Drive, Oxford OX3 7FZ, UK;3. The Norwegian Structural Biology Centre, Department of Chemistry, University of Tromsø, Tromsø, Norway;4. Novartis Institutes for BioMedical Research, Novartis Pharma AG, Postfach, CH-4002 Basel, Switzerland;5. Eli Lilly and Company, Lilly Research Laboratories, Lilly Corporate Center, DC 1931, Indianapolis, IN 46285, USA;6. University of Chicago, Dept. of Biochemistry & Molecular Biology, 929 E. 57th St., Chicago 60637, IL, USA;7. Department of Chemistry, Vanderbilt University, Nashville, TN 37232, USA;8. Astex Pharmaceuticals, 436 Cambridge Science Park, Milton Road, Cambridge CB4 0QA, United Kingdom;9. DiscoveRx Corporation, 42501 Albrae Street, Suite 100, Fremont, CA 94538, USA
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号